CYCN: Cyclerion Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.27
Enterprise Value ($M) 3.04
Book Value ($M) 8.85
Book Value / Share 3.49
Price / Book 0.71
NCAV ($M) 3.50
NCAV / Share 1.38
Price / NCAV 1.79

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.27

Liquidity (mrq)
Quick Ratio 5.83
Current Ratio 5.83

Balance Sheet (mrq) ($M)
Current Assets 4.22
Assets 9.57
Liabilities 0.72
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.00
Operating Income -3.63
Net Income -3.06
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.33
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A American Endowment Foundation 4.91 -95.00
02-12 13G/A Fmr Llc 0.20 -97.09
12-06 13G/A Slate Path Capital LP 0.00 -100.00
07-12 13G/A Artal International S.C.A. 4.30 -16.41
2024-02-14 13G/A Tyndall Capital Partners L P 6.70 35.18

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-04 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-14 1,189 7,664 15.51
2025-03-13 540 8,079 6.68
2025-03-12 4,597 11,246 40.88
2025-03-11 1,016 27,773 3.66
2025-03-10 1,980 20,830 9.51

(click for more detail)

Similar Companies
CUE – Cue Biopharma, Inc. CVKD – Cadrenal Therapeutics, Inc.
CYCC – Cyclacel Pharmaceuticals, Inc. CYRX – Cryoport, Inc.
CYTH – Cyclo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io